News for hackers. Stuff that matters.
Re:Cells edited using CRISPR–Cas9 injected into a person for... by ejstronge on Tuesday November 15, 2016 @07:59PM (#12963732)
I would be surprised if this safety trial were randomized with respect to the CRISPR manipulation. I agree with your assessment of needing more data to believe that the gene editing manipulation was successful.

I suspect the randomization relates to the allocation to the experimental arms as described on the reporting page:

    This is a dose-escalation study of ex-vivo knocked-out, 
    expanded, and selected PD-1 knockout-T cells from 
    autologous origin. Patients are assigned to 1 of 3  
    treatment groups to determine the maximal tolerant dose
Re:Cells edited using CRISPR–Cas9 injected into a person for... by nonbel on Wednesday November 16, 2016 @09:39AM (#12967173)
Nice catch, why do you think a safety trial should not use randomized allocation of the treatment (but it does make sense for dose) though?